Dr Reddys Laboratories (RDY) Return on Equity [ROE] (2009 - 2026)
Dr Reddys Laboratories' Return on Equity [ROE] came in at 7.36% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 9.13 percentage points from 16.49% a year earlier and down 1.70 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Return on Equity [ROE] was 11.30%, down 7.06 percentage points from FY2025.
- Return on Equity [ROE] carries a five-year change of +0.62 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Equity [ROE] was 18.36% in FY2025 (-3.27 pp), 21.63% in FY2024 (+1.05 pp), 20.58% in FY2023 (+7.83 pp) and 12.75% in FY2022 (+2.08 pp).
- The fiscal Q2 2027 figure represents the lowest quarterly Return on Equity [ROE] since fiscal Q4 2015.
- Year-over-year, Return on Equity [ROE] has declined for 11 consecutive quarters, with an average year-over-year change of -4.51 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q1 2024 (a gain of 9.85 percentage points), and the weakest in fiscal Q2 2027 (a drop of 9.13 percentage points).
- Business Quant data shows RDY's Return on Equity [ROE] at 9.05% (Q1 2027), 11.83% (Q4 2026) and 15.61% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.66% |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 7.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.36% |
| Jun 30, 2026 | 9.05% |
| Mar 31, 2026 | 11.83% |
| Dec 31, 2025 | 15.61% |
| Sep 30, 2025 | 16.49% |
| Jun 30, 2025 | 16.69% |
| Mar 31, 2025 | 17.60% |
| Dec 31, 2024 | 17.48% |
| Sep 30, 2024 | 17.99% |
| Jun 30, 2024 | 19.40% |
| Mar 31, 2024 | 20.55% |
| Dec 31, 2023 | 21.97% |
| Sep 30, 2023 | 21.33% |
| Jun 30, 2023 | 21.23% |
| Mar 31, 2023 | 20.94% |
| Dec 31, 2022 | 16.02% |
| Sep 30, 2022 | 13.67% |
| Jun 30, 2022 | 11.39% |
| Mar 31, 2022 | 11.32% |
| Dec 31, 2021 | 14.00% |
API Access
Dr Reddys Laboratories Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();